NCT00736073 A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis Status COMPLETED Phase NA
NCT00735839 V710 Clinical Study in Healthy Male Japanese Subjects (V710-006) (COMPLETED) Status COMPLETED Phase PHASE1
NCT00735826 A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer Status COMPLETED Phase NA
NCT00735345 Chemotherapy Induction and Chemoradiotherapy in Patients With Esophageal Carcinoma Status TERMINATED Phase PHASE2
NCT00734929 Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having Craniotomy Status COMPLETED Phase PHASE4
NCT00734344 Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection Status COMPLETED Phase NA
NCT00734266 Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary Disease Status COMPLETED Phase N/A
NCT00733889 A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma Status COMPLETED Phase PHASE2
NCT00733122 Tolerability and Immunogenicity of Gardasil in Females Between 16 and 23 Years of Age in India (V501-034) Status WITHDRAWN Phase PHASE3
NCT00732875 A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00732810 SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716) Status COMPLETED Phase PHASE2
NCT00732641 Peginterferon α-2b as a Maintenance Therapy in Participants With Multiple Myeloma Who Responded to Induction Therapy (P01972-AM7) Status COMPLETED Phase PHASE3
NCT00730912 Post Approval Pharmacokinetic Study of Loratadine in Japanese Pediatric and Adult Patients (Study P05539) Status COMPLETED Phase PHASE4
NCT00730704 Acceptance of Human Papillomavirus Vaccination in Postpartum Women Status COMPLETED Phase N/A
NCT00730431 Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002) Status COMPLETED Phase PHASE1
NCT00730379 A Combination Study With Ridaforolimus (MK8669) and Dalotuzumab (MK0646) in Patients With Advanced Cancer (8669-004) Status COMPLETED Phase PHASE1
NCT00730275 A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081) Status COMPLETED Phase PHASE1
NCT00729742 Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008) Status COMPLETED Phase PHASE1